SARS-CoV-2 Antibody Testing Linked to Increase in First-Time Blood Donors
Antibody testing after the early stages of the SARS-CoV-2 pandemic has significantly increased in the proportion of first-time blood donors.
All articles by Jonathan Goodman, MPhil
Caplacizumab Safe, Effective for Acquired Thrombotic Thrombocytopenic Purpura
Caplacizumab appears to be safe and effective among patients with acquired thrombotic thrombocytopenic purpura treated in the real-world setting.
